MarketInOut Stock Screener Log In | Sign Up
 

Orion Oyj Series A

HEL • Healthcare • Drug Manufacturers - General • Quote as of 08/07/2026
Orion Oyj Series A stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeHEL
Market Capitalization11,199 mln
Float123 mln
Earnings Date10/28/2026

EPS

4.18
Solid

P / E

19.47
Moderately valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.41
Manipulation likely

Relative Strength

65 / 100
Outperforming

Debt / Equity

0.29
Very low leverage

Business Description

Founded in Finland over a century ago, Orion Oyj is a pharmaceutical company that researches, produces, and sells a broad range of medicines for both people and animals across Europe, North America, and beyond. Its human health portfolio covers serious conditions such as prostate cancer, Parkinson's disease, heart failure, and respiratory illnesses like asthma and COPD, while its animal health range supports veterinary care worldwide. The company also manufactures active pharmaceutical ingredients, provides contract production services, and sells consumer health products including vitamins, skincare, and over-the-counter medicines. Orion works with partners such as Bayer and Tenax Therapeutics to bring new treatments to market.

Key Fundamentals

EPS4.18
P/E19.47
ROE48.91
RPS13.88
ROIC35.43
ROA28.82
Interest Cover155
EBITDA, mln668
EV / EBITDA16.32
EV / EBIT16.32
Revenue, mln1,953
EV / Revenue5.59

Financial Strength

Altman Z-Score9.88
Piotroski F-Score 6 / 9
Beneish M-Score-1.41
Price to Intrinsic Value2.97
Price to Lynch Fair Value1.25
Price to Graham Number3.34
Shiller PE Ratio34.87

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.87% 48 / 100   
1 Month 15.62% 89 / 100   
2 Months 19.53% 84 / 100   
6 Months 14.58% 86 / 100   
1 Year 17.95% 75 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us